Nasdaq-Listed BioNexus Becomes First Public Firm to Approve Ethereum Treasury
BioNexus Gene Lab Corporation has formally approved an Ethereum-focused treasury strategy Wednesday, becoming the first Nasdaq-listed company to exclusively prioritize Ethereum as a strategic asset. The Wyoming-incorporated tech firm released its Ethereum Strategy Whitepaper alongside […]
